First Pancreatic Cancer Breakthrough in 30 Years Now Available

After 30 years without new options, pancreatic cancer patients finally have a reason to hope.

Frederick Health in Maryland became the first hospital in America to offer Tumor Treating Fields therapy, a newly FDA-approved treatment that's already changing lives. The breakthrough comes for locally advanced pancreatic cancer, one of the most challenging diseases doctors face.

The therapy works differently than anything before it. Patients wear patches connected to a portable device that sends low-intensity electrical fields into the tumor, disrupting cancer cell division without surgery or added side effects. Combined with standard chemotherapy, the treatment helps patients live longer while maintaining their quality of life.

What makes this even better is where treatment happens. Instead of spending days in hospitals, patients receive the therapy at home while their doctors monitor progress remotely.

Dr. Saro Sarkisian, a board-certified oncologist at Frederick Health, became the first physician in the United States certified to treat pancreatic cancer patients with this technology. His passion for the breakthrough is personal after watching too many patients lose their battles over the years.

"Over the past two or three decades, we have not seen a successful treatment for our patients with pancreatic cancer," Dr. Sarkisian explained. "So now there is hope."

The Ripple Effect

This advancement reaches far beyond Frederick. Families who've watched loved ones struggle with limited options now have something they haven't had in a generation: genuine hope. The treatment not only extends survival but delays painful disease progression, giving patients more quality time with the people they love.

Dr. Sarkisian's humility about being first reflects the medical community's dedication to pushing boundaries. His focus remains clear: helping patients live longer, better lives while continuing to advance the science.

The therapy's home-based approach also means less disruption to daily life. Patients can spend time with family, pursue hobbies, and maintain normalcy while fighting their disease.

Medical innovation often moves slowly, but this breakthrough proves that persistence pays off. After three decades of limited progress, researchers and clinicians never stopped searching for better answers. Their determination created a treatment that preserves dignity while extending life.

For every family touched by pancreatic cancer, this moment represents more than medical progress—it's proof that tomorrow can bring solutions today couldn't imagine.